Amlodipine and Hyperparathyroidism primary - a phase IV clinical study of FDA data

Summary:

Hyperparathyroidism primary is reported as a side effect among people who take Amlodipine (amlodipine besylate), especially for people who are female, 60+ old, also take Omega-3 Fatty Acids, and have Breast cancer.

The phase IV clinical study analyzes which people have Hyperparathyroidism primary when taking Amlodipine. It is created by eHealthMe based on reports of 346,875 people who have side effects when taking Amlodipine from the FDA, and is updated regularly.

What is Amlodipine?

Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,830 Amlodipine users. Check the latest studies of Amlodipine.

What is Hyperparathyroidism primary?

Hyperparathyroidism primary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium- primary) is found to be associated with 50 drugs and 133 conditions by eHealthMe. Check the latest studies of Hyperparathyroidism primary.

On Aug, 09, 2026

346,875 people reported to have side effects when taking Amlodipine.
Among them, 13 people (0.0%) have Hyperparathyroidism primary.

Could Amlodipine cause Hyperparathyroidism primary?

Among these 13 people:

What is the gender of people who have Hyperparathyroidism primary when taking Amlodipine? *

female: 100 %
male: 0.0 %

What is the age of people who have Hyperparathyroidism primary when taking Amlodipine? *

What are other drugs people take besides Amlodipine? *

What are other side effects people have besides Hyperparathyroidism primary? *

Hypercalcaemia (elevated calcium (ca+) level in the blood): 9 people, 69.23%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 23.08%
Fatigue (feeling of tiredness): 3 people, 23.08%
Parathyroid Tumor Benign: 3 people, 23.08%
Osteoporosis (bones weak and more likely to break): 2 people, 15.38%
Dizziness: 2 people, 15.38%
Nausea (feeling of having an urge to vomit): 2 people, 15.38%
Confusional State: 2 people, 15.38%
Blood Parathyroid Hormone Increased: 2 people, 15.38%
Swallowing Difficulty: 2 people, 15.38%

What are the existing conditions these people have? *

Type 2 Diabetes: 2 people, 15.38%
Breast Cancer: 2 people, 15.38%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 7.69%
Pain: 1 person, 7.69%
Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 1 person, 7.69%
Diabetes: 1 person, 7.69%
Dementia (madness): 1 person, 7.69%
Cardiac Failure: 1 person, 7.69%
Cardiac Disorder: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine and have Hyperparathyroidism primary?

- Check whether Hyperparathyroidism primary is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amlodipine:

Amlodipine (354,830 reports)

Browse all side effects of Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperparathyroidism primary:

Hyperparathyroidism primary (50 drugs)

Browse all the conditions that are associated with Hyperparathyroidism primary:

Hyperparathyroidism primary (133 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Amlodipine) and Amlodipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.